Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Novel mechanism of thrombosis: Role of the í3 integrin PSI domain in blood coagulation

EF 2016-17

Résumé
Cardiovascular diseases, such as heart attack and stroke, are the number one cause of death globally. In Canada, over 1.6 million Canadians are living with heart disease or stroke. Platelets are essential cells in blood coagulation (clotting) upon vessel injury; however, inappropriate platelet activation can result in these devastating cardiovascular diseases. Current anti-platelet therapies can lead to patients experiencing intolerable, life-threatening side effects, such as, severe bleeding and low platelet counts. Therefore, novel therapeutic approaches need to be explored. My proposed study focuses on a surface protein receptor called integrin ?IIb?3 which is imperative for platelet function. A portion of this protein, the plexin-semaphorin-integrin (PSI) domain, has been shown to contribute to platelet function. Our lab discovered that the PSI domain of ?IIb?3 can rearrange specific chemical bonds (called disulfide bonds) within proteins which is likely how it contributes to platelet activity. During blood clotting, disulfide bonds within coagulation factors (proteins in close proximity to the PSI domain on the platelet surface) can be rearranged. Therefore, it is very likely that the PSI domain can support coagulation by rearranging disulfide bonds within coagulation factors. Our lab has created antibodies that bind specifically to the PSI domain of integrin ?IIb?3. I will use these antibodies to test the role of PSI in blood coagulation. This study will fill a gap in current research regarding the role of the PSI domain in blood clotting and may ultimately help develop a new class of anti-platelet therapeutics to treat cardiovascular diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367341
Name
Stratton Tyler
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Novel mechanism of thrombosis: Role of the í3 integrin PSI domain in blood coagulation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aggregation; Blood Coagulation; Cardiovascular Disease; Hemostasis; Integrin Aiibí3; Phosphatidylserine (Ps) Exposure; Platelet Activation; Plexin-Semaphorin-Integrin; Thiol-Isomerase; Thrombosis
Abstract
Cardiovascular diseases, such as heart attack and stroke, are the number one cause of death globally. In Canada, over 1.6 million Canadians are living with heart disease or stroke. Platelets are essential cells in blood coagulation (clotting) upon vessel injury; however, inappropriate platelet activation can result in these devastating cardiovascular diseases. Current anti-platelet therapies can lead to patients experiencing intolerable, life-threatening side effects, such as, severe bleeding and low platelet counts. Therefore, novel therapeutic approaches need to be explored. My proposed study focuses on a surface protein receptor called integrin ?IIb?3 which is imperative for platelet function. A portion of this protein, the plexin-semaphorin-integrin (PSI) domain, has been shown to contribute to platelet function. Our lab discovered that the PSI domain of ?IIb?3 can rearrange specific chemical bonds (called disulfide bonds) within proteins which is likely how it contributes to platelet activity. During blood clotting, disulfide bonds within coagulation factors (proteins in close proximity to the PSI domain on the platelet surface) can be rearranged. Therefore, it is very likely that the PSI domain can support coagulation by rearranging disulfide bonds within coagulation factors. Our lab has created antibodies that bind specifically to the PSI domain of integrin ?IIb?3. I will use these antibodies to test the role of PSI in blood coagulation. This study will fill a gap in current research regarding the role of the PSI domain in blood clotting and may ultimately help develop a new class of anti-platelet therapeutics to treat cardiovascular diseases.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stratton, Tyler
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~